Science 37 Holdings Inc (SNCE)

Sector:
FINANCE
Industry:
CORPORATE FINANCE
SIC:
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
CEO:
David Coman
Employees:
600
600 CORPORATE POINTE, SUITE 320, CULVER CITY, CA, 90230
(984)377-3737

Science 37 Holdings, Inc. engages in the development of a technology platform to enable agile clinical trials and specialized networks to orchestrate trial execution. Platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices.

Data derived from most recent annual or quarterly report
Market Cap 237.556 Million Shares Outstanding115.881 Million Avg 30-day Volume 500.403 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue8.6426 Debt to Equity0.0 EBITDA-49.534 Million
Price to Book Value3.8843 Operating Margin-120.89460000000001 Enterprise Value497.021 Million
Current Ratio6.402 EPS Growth0 Quick Ratio6.143
1 Yr BETA 1.2165 52-week High/Low 15.1 / 1.61 Profit Margin-63.1515
Operating Cash Flow Growth0.0 Altman Z-Score6.416 Free Cash Flow to Firm 0
View SEC Filings from SNCE instead.

View recent insider trading info

Funds Holding SNCE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SNCE

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-13:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-22:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-20:
    Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
  • 8-K/A: filed on 2021-11-15:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-13:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.02: Unregistered Sales of Equity Securities
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 4.01: Changes in Registrant's Certifying Accountant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.06: Change in Shell Company Status
    Item 8.01: Other Events
    Item 5.01: Changes in Control of Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-06:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2021-05-07:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    68.1 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    FORMAN DARCY CHIEF DELIVERY OFFICER

    • Officer
    178,531 2022-06-29 5

    REDMILE GROUP, LLC

    GREEN JEREMY

    • Director
    • 10% Owner
    19,849,217 2022-06-13 6

    HUBBARD JOHN W

    • Director
    40,983 2022-05-23 4

    FAULKNER ROBERT C.

    • Director
    40,983 2022-05-23 3

    ROLLINS EMILY

    • Director
    40,983 2022-05-23 3

    GOULBURN ADAM

    • Director
    40,983 2022-05-23 4

    TIWARI NEIL

    • Director
    40,983 2022-05-23 3

    PELLIZZARI CHRISTINE A CHIEF LEGAL OFFICER

    • Officer
    50,000 2022-05-20 5

    COTLIAR JONATHAN CHIEF MEDICAL OFFICER

    • Officer
    845,612 2022-04-20 6

    LUX CAPITAL MANAGEMENT, LLC

    LUX VENTURES IV, L.P.

    LUX VENTURE PARTNERS IV, LLC

    LUX CO-INVEST OPPORTUNITIES, L.P.

    LUX CO-INVEST PARTNERS, LLC

    HEBERT PETER

    WOLFE JOSH

    • 10% Owner
    12,249,889 2022-04-04 2

    ZARANEK MIKE CHIEF FINANCIAL OFFICER

    • Officer
    185,897 2022-01-07 4

    GEFFON STEVEN CHIEF COMMERCIAL OFFICER

    • Officer
    211,538 2022-01-07 4

    COMAN DAVID CHIEF EXECUTIVE OFFICER

    • Officer
    557,692 2022-01-07 4

    THERMO FISHER SCIENTIFIC INC.

    17,379,797 2021-12-08 2

    THERMO FISHER SCIENTIFIC INC.

    THERMO FISHER SCIENTIFIC POWDER US HOLDINGS CORP.

    17,379,797 2021-12-08 2

    PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC

    WILDCAT ACQUISITION HOLDINGS (UK) LTD

    JAGUAR HOLDING CO II

    JAGUAR HOLDING CO I, LLC

    EAGLE HOLDING CO II, LLC

    PPD, INC.

    • 10% Owner
    17,314,315 2021-10-06 2

    DE SILVA BHOOSHITHA B.

    • Director
    0 2021-10-06 1

    MCDONALD ANDREW I CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    • 10% Owner
    1,772,034 2021-08-25 1

    RICE MICHAEL YEHUDA CHIEF OPERATING OFFICER

    • Officer
    • Director
    • 10% Owner
    1,772,034 2021-08-25 1

    LIFESCI HOLDINGS LLC

    • 10% Owner
    1,772,034 2021-08-25 1

    JANSSEN SCOTT

    • Director
    6,000 2020-11-20 0

    MATHERS THOMAS P.

    • Director
    6,000 2020-11-20 0

    BARRETT ELIZABETH A.

    • Director
    6,000 2020-11-20 0

    GRAHAM G. WALMSLEY

    • Director
    6,000 2020-11-20 0

    DOBKIN DAVID CHIEF FINANCIAL OFFICER

    • Officer
    • Director
    0 2020-11-20 0

    WYNN THOMAS JOSEPH III

    • Director
    6,000 2020-11-20 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    FORMAN DARCY - Officer CHIEF DELIVERY OFFICER

    2022-07-01 16:08:34 -0400 2022-06-29 M 68,075 $0.28 a 110,456 direct -0.4902 -4.4118 6.3725 4 -4.4118 6

    FORMAN DARCY - Officer CHIEF DELIVERY OFFICER

    2022-07-01 16:08:34 -0400 2022-06-29 M 68,075 d 68,075 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 22:15:04 UTC -1.1704 3.4904 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 21:45:04 UTC -1.1704 3.4904 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 21:15:04 UTC -1.1704 3.4904 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 20:45:04 UTC -1.1233 3.4433 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 20:15:03 UTC -1.1233 3.4433 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 19:45:04 UTC -1.1233 3.4433 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 19:15:04 UTC -1.1233 3.4433 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 18:45:04 UTC -1.1493 3.4693 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 18:15:04 UTC -1.1493 3.4693 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 17:45:04 UTC -1.1493 3.4693 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 17:15:03 UTC -1.1493 3.4693 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 16:45:04 UTC -1.1127 3.4327 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 16:15:04 UTC -1.1127 3.4327 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 15:45:04 UTC -1.1127 3.4327 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 15:15:04 UTC -1.1127 3.4327 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 14:45:04 UTC -1.1127 3.4327 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 14:15:03 UTC -1.1127 3.4327 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 13:45:04 UTC -0.9172 3.2372 1400000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 13:15:04 UTC -0.9172 3.2372 1100000
    SCIENCE 37 HOLDINGS INC SNCE 2022-08-15 12:45:04 UTC -0.9172 3.2372 1100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund SNCE -700.0 shares, $-3745.0 2022-03-31 N-PORT

    Elevate your investments